nach oben

Erschienen in:

20.10.2018 | Apoplex | Zertifizierte Fortbildung

Schlaganfallätiologie wichtig für Therapieentscheidung

Studien zur interventionellen Schlaganfallprävention — ein Update

verfasst von: Dr. med. Sven Lerch

Erschienen in: CardioVasc | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Zusammenfassung

Interventionelle Behandlungsstrategien sind eine Säule in der Primär- und vor allem Sekundärprävention des Schlaganfalls. Dabei ist ihre Bedeutung je nach Schlaganfallätiologie sehr unterschiedlich. Die Neuerungen in diesem Behandlungsbereich — mit Schwerpunkt hinsichtlich der kardialen Interventionen — werden hier vorgestellt und in ihrer klinischen Wertigkeit diskutiert.

www.gbe-bund.de

Adams HP Jr, Bendixen BH, Kappelle LJ et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35–41CrossRef

Li L, Yiin GS, Geraghty OC et al. Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study. Lancet Neurol. 2015;14(9):903–13CrossRef

Holmes DR, Reddy VY, Turi ZG et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009;374(9689):534–42CrossRef

Holmes DR Jr, Kar S, Price MJ et al. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014;64(1):1–12CrossRef

Reddy VY, Doshi SK, Kar S et al. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials. J Am Coll Cardiol. 2017;70(24):2964–75CrossRef

Osmancik P, Tousek P, Herman D et al. Interventional left atrial appendage closure vs novel anticoagulation agents in patients with atrial fibrillation indicated for long-term anticoagulation (PRAGUE-17 study). Am Heart J. 2017;183:108–14CrossRef

https://closure-af.dzhk.de

Furlan AJ, Reisman M, Massaro J et al. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med. 2012;366(11):991–9CrossRef

10.

Carroll JD, Saver JL, Thaler DE et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med. 2013;368(12):1092–100CrossRef

11.

Meier B, Kalesan B, Mattle HP et al. Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med. 2013;368(12):1083–91CrossRef

12.

Kernan WN, Ovbiagele B, Black HR et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(7):2160–236CrossRef

13.

Messé SR, Gronseth G, Kent DM et al. Practice advisory: Recurrent stroke with patent foramen ovale (update of practice parameter): Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2016;87(8):815–21CrossRef

14.

Mas JL, Derumeaux G, Guillon B et al. Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke. N Engl J Med. 2017;377(11):1011–21CrossRef

15.

Søndergaard L, Kasner SE, Rhodes JF et al. Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke. N Engl J Med. 2017;377(11):1033–42CrossRef

16.

Saver JL, Carroll JD, Thaler DE et al. Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke. N Engl J Med. 2017;377(11):1022–32CrossRef

17.

Lee PH, Song JK, Kim JS et al. Cryptogenic Stroke and High-Risk Patent Foramen Ovale: The DEFENSE-PFO Trial. J Am Coll Cardiol. 2018;71(20):2335–42CrossRef

18.

Chimowitz MI, Lynn MJ, Derdeyn CP et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011;365(11):993–1003CrossRef

19.

Derdeyn CP, Chimowitz MI, Lynn MJ et al. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet. 2014;383(9914):333–41CrossRef

20.

Zaidat OO, Fitzsimmons BF, Woodward BK et al. Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial. JAMA. 2015;313(12):1240–8CrossRef

21.

Gao P, Zhao Z, Wang D et al. China Angioplasty and Stenting for Symptomatic Intracranial Severe Stenosis (CASSISS): A new, prospective, multicenter, randomized controlled trial in China. Interv Neuroradiol. 2015;21(2):196–204CrossRef

22.

Cui XP, Lin M, Mu JS et al. Angioplasty and stenting for patients with symptomatic intracranial atherosclerosis: study protocol of a randomised controlled trial. BMJ Open. 2016;6(11):e012175CrossRef

23.

Ma Y, Gu Y, Tong X et al. The Carotid and Middle cerebral artery Occlusion Surgery Study (CMOSS): a study protocol for a randomised controlled trial. Trials. 2016;17(1):544CrossRef

24.

Barnett HJ, Taylor DW, Eliasziw M et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med. 1998;339(20):1415–25CrossRef

25.

European Carotid Surgery Trialists’ Collaborative Group. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet. 1998;351(9113):1379–87CrossRef

26.

Asymptomatic Carotid Atherosclerosis Study Group. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA. 1995;273(18):1421–8CrossRef

27.

Rothwell PM, Eliasziw M, Gutnikov SA et al. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet. 2003;361(9352):107–16CrossRef

28.

Toole JF, Baker WH, Castaldo JE et al. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA. 1995;273(18):1421–8CrossRef

29.

Halliday A, Harrison M, Hayter E et al. 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial. Lancet. 2010;376(9746):1074–84CrossRef

30.

Eckstein HH, Reiff T, Ringleb P et al. SPACE-2: A Missed Opportunity to Compare Carotid Endarterectomy, Carotid Stenting, and Best Medical Treatment in Patients with Asymptomatic Carotid Stenoses. Eur J Vasc Endovasc Surg. 2016;51(6):761–5CrossRef

31.

Howard VJ, Meschia JF, Lal BK et al. Carotid revascularization and medical management for asymptomatic carotid stenosis: Protocol of the CREST-2 clinical trials. Int J Stroke. 2017;12(7):770–8CrossRef

32.

The 2nd European ECST-2 Carotid Surgery Trial. Retrieved from: http://s489637516.websitehome.co.uk/ECST2/index2.htm

33.

Reinacher PC, Coenen VA, Kraeutle R et al. Feasibility of stereotactic catheter ventriculocisternostomy for cisternal lavage therapy in patients with subarachnoid hemorrhage. Clin Neurol Neurosurg. 2017;163:94–102CrossRef

34.

Roelz R, Coenen VA, Scheiwe C et al. Stereotactic Catheter Ventriculocisternostomy for Clearance of Subarachnoid Hemorrhage: A Matched Cohort Study. Stroke. 2017;48(10):2704–9CrossRef

Titel: Schlaganfallätiologie wichtig für Therapieentscheidung
Studien zur interventionellen Schlaganfallprävention — ein Update
verfasst von: Dr. med. Sven Lerch
Publikationsdatum: 20.10.2018
Verlag: Springer Medizin
Schlagwörter: Apoplex
Karotisstenose
Karotisstenose
Erschienen in: CardioVasc / Ausgabe 5/2018
Print ISSN: 1617-4933
Elektronische ISSN: 1618-3851
DOI: https://doi.org/10.1007/s15027-018-1240-3

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2018

Erste Dreifachkombination mit Indapamid verfügbar

NOAK: Dosierung richtig wählen, Therapietreue optimieren

Wenn Jugendliche beim Fußballspiel tot umfallen

Der kardiorenale Patient: Auf Eisenmangel und Hyperkaliämie achten!

Neue Leitlinie: Wie man Schwangere mit Herzerkrankungen richtig betreut

Leitlinien-Änderung beim kardiogenen Schock bestätigt